TGFB1 and cancer: In addition, Jiang et al. presented that ANO1 could inhibit gastrointestinal cancer ferroptosis in a PI3K-Akt signaling-dependent manner and stimulate the production and secretion of TGF‐β by cancer cells, which in turn recruits CAFs in the TME and confers immunotherapeutic resistance [167].